Melanie Kelly
Direttore Tecnico/Scientifico/R&S presso Panag Pharma, Inc.
Profilo
Melanie Kelly is currently the Executive Director & Member of the International Cannabinoid Research Society, Director at The Canadian Consortium for the Investigation of Cannabinoids, Professor at Dalhousie University, and Chief Scientific Officer at Panag Pharma, Inc. She was formerly the Chief Scientific Officer at Tetra Bio-Pharma, Inc.
Posizioni attive di Melanie Kelly
| Società | Posizione | Inizio |
|---|---|---|
| Dalhousie University | Corporate Officer/Principal | 01/07/1991 |
| International Cannabinoid Research Society | Direttore/Membro del Consiglio | 01/07/2017 |
| The Canadian Consortium for the Investigation of Cannabinoids | Direttore/Membro del Consiglio | - |
Panag Pharma, Inc.
 Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Direttore Tecnico/Scientifico/R&S | 01/07/2014 |
Precedenti posizioni note di Melanie Kelly
| Società | Posizione | Fine |
|---|---|---|
| TETRA BIO-PHARMA INC. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| International Cannabinoid Research Society | |
| The Canadian Consortium for the Investigation of Cannabinoids | |
Panag Pharma, Inc.
Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Health Technology |
- Borsa valori
- Insiders
- Melanie Kelly
